NPPB and hydrops fetalis: High-sensitive C-reactive protein (hs-CRP) has also markedly improved the risk stratification of acute HF and acutely decompensated HF patients in multibiomarker models, which predominantly included MR-proADM and NT-proBNP [131, 132].